As of the end of fiscal year 2024, Tracenable has captured detailed data on Dexcom's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group.a
The dataset includes information on 3 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to Dexcom's consolidated operations.a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
DEXCOM INTERNATIONAL LIMITEDa | CYP | Subsidiary | Not Specified | ||
ROADRUNNER GREEN LIMITEDa | IRL | Subsidiary | Not Specified | ||
DEXCOM (MALAYSIA) SDN. BHD.a | MYS | Subsidiary | Not Specified |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
Tracenable's group entities dataset provides geographic insights into Dexcom's significant subsidiaries, revealing their location around the world.a
In total, the Dexcom group includes 3 significant subsidiaries distributed across 3 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure.a
This visualization highlights the geographical distribution of Dexcom's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.a
In 2024, Tracenable identified that the Dexcom group consisted of3 significant subsidiaries, located across 3 countries.a
This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network.a
Dexcom's significant subsidiaries are primarily located in Europe and Asia, which together host 100% of its material entities.a
This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.
Dexcom exhibits a limited level of transparency concerning its corporate ownership structure.
The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance.a
Without full group hierarchy or equity details, it offers a restricted view of Dexcom's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.
No. Tracenable's data does not indicate any entities registered in jurisdictions typically categorized as low-tax or offshore financial centers, suggesting that Dexcom's ownership network is primarily domiciled in standard corporate jurisdictions or that Dexcom does not provide full transparency on its corporate structure.a